The Microbiota–Gut–Brain Axis and Alzheimer’s Disease: Neuroinflammation Is to Blame?
Open accessThe DOI matches its Crossref record; 251 of the 253 references it cites were found in a registry or an index.
Abstract
For years, it has been reported that Alzheimer’s disease (AD) is the most common cause of dementia. Various external and internal factors may contribute to the early onset of AD. This review highlights a contribution of the disturbances in the microbiota–gut–brain (MGB) axis to the development of AD. Alteration in the gut microbiota composition is determined by increase in the permeability of the gut barrier and immune cell activation, leading to impairment in the blood–brain barrier function that promotes neuroinflammation, neuronal loss, neural injury, and ultimately AD. Numerous studies have shown that the gut microbiota plays a crucial role in brain function and changes in the behavior of individuals and the formation of bacterial amyloids. Lipopolysaccharides and bacterial amyloids synthesized by the gut microbiota can trigger the immune cells residing in the brain and can activate the immune response leading to neuroinflammation. Growing experimental and clinical data indicate the prominent role of gut dysbiosis and microbiota–host interactions in AD. Modulation of the gut microbiota with antibiotics or probiotic supplementation may create new preventive and therapeutic options in AD. Accumulating evidences affirm that research on MGB involvement in AD is necessary for new treatment targets and therapies for AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This process is accompanied by imbalanced neurotransmission,218 which ultimately leads to neuronal degeneration and damage.”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [218]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385 · cited 1×
“The immune system modulates the gut microbiota framework and issuance [171], while in return, the microbial symbionts control immune system maturation and function [172,173].”
BackgroundAFRC, R. F. (1989) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1989.tb05105.x · Cited by 4,149 · cited 1×
“Probiotics are defined as living microbial feed supplements which show a beneficial effect on the host, resulting in improved intestinal microbial balance [230].”
BackgroundHost microbiota constantly control maturation and function of microglia in the CNS
Erny, D., Hrabě de Angelis, A. L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4030 · Cited by 3,569 · cited 2×
“SCFA claimed to reestablish microglial density and normalized CSF1R surface expression [203].”
BackgroundComplement and microglia mediate early synapse loss in Alzheimer mouse models
Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343
Gut microbiota composition correlates with diet and health in the elderly
Claesson, M. J., Jeffery, I. B., Conde, S., Power, S. E., O’Connor, E. M., Cusack, S., Harris, H. M. B., Coakley, M., Lakshminarayanan, B., O’Sullivan, O., et al. (2012) · Nature · doi:10.1038/nature11319 · Cited by 3,314 · cited 1×
“The individuals in the nursing home had less microbiota attributed to a limited diet [59].”
BackgroundGut Microbiota Regulation of Tryptophan Metabolism in Health and Disease
Agus, A., Planchais, J., & Sokol, H. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.05.003 · Cited by 3,180
Role of the normal gut microbiota
Jandhyala, S. M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i29.8787 · Cited by 3,001 · cited 9×
“Claims on the potential involvement of the gut microbiota in brain function are made, in part, due to the well-described pathways of communication between the brain and the GIT which has been intensively studied in the area of food intake, satiety, and regulation of the digestive tract [109].”
BackgroundInfluentialDietary polyphenols and the prevention of diseases
Scalbert, A., Manach, C., Morand, C., Rémésy, C., & Jiménez, L. (2005) · Critical Reviews in Food Science and Nutrition · doi:10.1080/1040869059096 · Cited by 2,999
Gut microbiota functions: metabolism of nutrients and other food components
Rowland, I., Gibson, G., Heinken, A., Scott, K., Swann, J., Thiele, I., & Tuohy, K. (2018) · European Journal of Nutrition · doi:10.1007/s00394-017-1445-8 · Cited by 2,878 · cited 1×
“These findings suggest that the microbiota performs numerous vital functions in our body, including releasing biochemical by-products such as SCFA and gases [88].”
BackgroundDel Rio, D., Rodriguez-Mateos, A., Spencer, J. P. E., Tognolini, M., Borges, G., & Crozier, A. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4581 · Cited by 2,601
Cited by
Items 201–300 of 347
Anti-Alzheimer’s and Anti-inflammatory Activities of Compounds Isolated from Solanum Mauritianum
Ticona, L. A., García, B., Bastante, M. H., Șerban, A. M., & Sánchez, Á. R. (2022) · Planta Medica International Open · doi:10.1055/a-1696-6741 · Cited by 10
Dumitru, C. N., Dumitru, A. O., Popa, G. V., Marcu, T., Ursu, M., Nechita, A., & Matei, N. M. (2026) · Dentistry Journal · doi:10.3390/dj14050289 · Cited by 6
“In particular, miR-146a and miR-155, which modulate NF-κ B signaling and inflammatory gene expression, are differentially expressed in the saliva of periodontitis patients and represent potential biomarkers of inflammatory regulation [115,125].”
Diet as a Modulator of Gut Microbiota May Reduce Alzheimer’s Disease Risk
Ochocińska, A., Podstawka, I., Kępka, A., & Waszkiewicz, N. (2025) · Nutrients · doi:10.3390/nu17193053 · Cited by 6
“Amyloids secreted by bacteria, such as Escherichia coli , affect the abnormal folding of the alpha-synuclein protein, leading to an increased risk of AD [19,20,27–29].”
InfluentialMarsh, E. B., Lavretsky, H., Kasparian, N. A., Pike, N. A., Doyle, K. P., Aggarwal, N. T., Fullerton, H. J., Ivy, A. S., & Dlamini, N. (2026) · Stroke · doi:10.1161/str.0000000000000518 · Cited by 6
Wang, W., Zhang, J., & Li, C. (2024) · The International Journal of Psychiatry in Medicine · doi:10.1177/00912174241290962 · Cited by 6
Yin, M., Peng, J., Chen, M., Zhan, Q., & Zhong, H. (2025) · Journal of Medicinal Food · doi:10.1089/jmf.2024.k.0160 · Cited by 6
Gut-brain connection in schizophrenia: A narrative review
Iqbal, A., Bokhari, S. F. H., Rehman, M. U., Sattar, S. M. F., Bakht, D., Dost, W., & Basit, A. (2025) · World Journal of Psychiatry · doi:10.5498/wjp.v15.i5.103751 · Cited by 7
Zhu, W., Yuan, Y., Guan, X., Xie, Q., Sun, X., & Dong, Z. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123750 · Cited by 7
Darbandi, N., Komijani, M., & Tajiani, Z. (2023) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24942 · Cited by 6
Téllez‐Isaías, G., & Latorre, J. D. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.857583 · Cited by 6
Cinnamomum cassia Alleviates Neuropsychiatric Lupus in a Murine Experimental Model
Maalouly, G., Saliba, Y., Hajal, J., Zein-El-Din, A., Fakhoury, L., Najem, R., Smayra, V., Nassereddine, H., & Farès, N. (2025) · Nutrients · doi:10.3390/nu17111820 · Cited by 5
Ge, L., Zhu, L., Su, C., & Jin, Z. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251360004 · Cited by 5
Assad, A., Jonhson, S. L., & Reichard, R. A. (2025) · Cureus · doi:10.7759/cureus.89302 · Cited by 7
“…is now well-established that the gut and brain communicate and modulate each other through the gut-brain axis and that both derangement of the gut microbiome and gut inflammation compromise the blood-brain barrier (BBB), contributing to neuroinflammation, neuronal death, and ultimately AD [38-40].”
Birmann, P. T., Zugno, G. P., Sinott, A., Rodrigues, R. R., Conceição, F. R., Sousa, F. S. S., Collares, T. V., Seixas, F. K., & Savegnago, L. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05267-9 · Cited by 5
“Within the given frame of reference, therapeutic strategies that modulate the intestine microbial composition toward increasing the population of beneficial bacteria, such as Bacteroidetes and Lactobacillus , are of the utmost importance [44].”
Tian, M., Wang, D., Zhang, C., Fan, J., Li, W., Liu, X., & Shi, J. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6c00173 · Cited by 6
The complex of gut microbial metabolites and sex hormones in Alzheimer’s disease
Bahar, A., Khazaei, M., & Tahmasebi, H. (2026) · Seminars in Immunopathology · doi:10.1007/s00281-026-01076-x · Cited by 5
Unraveling Alzheimer’s: Exploring the Gut Microbiota–Brain Axis as a New Frontier in Understanding
Rashid, S. M., Razak, R., Tantray, A. K., James, A. W., Showkat, N., Shehjar, F., Jan, F., Ahmad, S. B., Khan, A., & Shah, Z. A. (2024) · Journal of dementia and Alzheimer's disease · doi:10.3390/jdad1010003 · Cited by 5
Eladawy, R. M., Ahmed, L. A., Salem, M. B., Hammam, O. A., Mohamed, A. F., Salem, H. A., & El‐Sayed, R. M. (2024) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2024.117126 · Cited by 5
Jin, J., Lü, L., Hua, K., Fang, L., Li, X., & Li, W. (2024) · Current Alzheimer Research · doi:10.2174/0115672050341904241111082935 · Cited by 5
Peyer’s Patch: Possible target for modulating the Gut-Brain-Axis through microbiota
Asgari, R., Bazzazan, M. A., Jirandehi, A. K., Yousefzadeh, S., Alaei, M., & Shahbaz, S. K. (2024) · Cellular Immunology · doi:10.1016/j.cellimm.2024.104844 · Cited by 6
Navigating the Role and Approach of Gut Microbiota in Addressing Alzheimer's Disease Pathogenesis
Jazuli, I., Jazeel, A., Selvaratnam, L., Alex, D., & Kumari, Y. (2024) · Progress In Microbes & Molecular Biology · doi:10.36877/pmmb.a0000454 · Cited by 10
“This signifies a need for therapeutic strategies to alter amyloids produced by bacteria [70, 131-134] .”
Liver Microbiome in Healthy Rats: The Hidden Inhabitants of Hepatocytes
Sun, X., Zhang, H., Zhang, X., Xin, P. F., Gao, X., Li, H. R., Zhou, C. Y., Gao, W. M., Kou, X. X., & Zhang, J. G. (2023) · Cellular Microbiology · doi:10.1155/2023/7369034 · Cited by 5
Aydin, B., & Cansev, M. (2025) · Pharmacological Reports · doi:10.1007/s43440-025-00788-5 · Cited by 4
“Dysbiosis can lead to increased intestinal permeability, allowing pro-inflammatory cytokines to enter the bloodstream and reach the brain, potentially contributing to neuroinflammation and neuropathologies such as neurodegenerative diseases and mood disorders [128–130].”
Burkhart, G., Grabinski, S. E., Wang, J., Glusauskas, G., Thompson, A., Lee, A., Zhu, Z., Donskey, C. J., von Recum, H. A., Zhang, L., et al. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123834 · Cited by 4
Samulenaite, S., Parkitna, J. M. R., Baltriukienė, D., Martín‐García, E., Maldonado, R. J., & Burokas, A. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2647535 · Cited by 4
Self-citationCarro-Rodríguez, J., Ibáñez-Cervantes, G., Cárdenas‐Rodríguez, N., Ignacio‐Mejía, I., Albores-Mendez, E. M., Pardo-Pacheco, B. R., Fernández-Sánchez, V., Balboa-Verduzco, A. M., Adame, C., Lara‐Padilla, E., et al. (2026) · Antioxidants · doi:10.3390/antiox15040522 · Cited by 4
Zhang, B., Zhang, D., Chen, K., & Wu, T. (2025) · APOPTOSIS · doi:10.1007/s10495-024-02073-x · Cited by 4
Preventive effects of xanthohumol in APP/PS1 mice based on multi-omics atlas
Liu, W., Chen, X., Chen, Y., Lin, Z., Huang, X., Zhang, Z., & Liu, J. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111316 · Cited by 4
“Moreover, gut microbiota play a crucial role in the development of AD by changing brain function and individual behavior (Faulin TDES, et al. 2023; Megur A, et al. 2020).”
Pathogen infection in Alzheimer’s disease: pathophysiology and therapeutic strategies
Xiong, M., Yu, H., Tian, Y., Meng, L., & Zhang, Z. (2023) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2022.32 · Cited by 4
Alterations in Peripheral Metabolites as Key Actors in Alzheimer’s Disease
Sheng, C., Chu, X., He, Y., Ding, Q., Jia, S., Shi, Q.-G., Sun, R., Li, S., Du, W., Liang, Y., et al. (2023) · Current Alzheimer Research · doi:10.2174/1567205020666230825091147 · Cited by 4
Klebsiella pneumoniae infection increases risk of Alzheimer's disease in the UK Biobank cohort
Lehrer, S. P., & Rheinstein, P. H. (2025) · Psychogeriatrics · doi:10.1111/psyg.70013 · Cited by 4
The role of Gut-Microbiome-Brain-axis in Alzheirmer's disease
Rocha, V. M. N., Rocha, V. M. N., Gomes, G. F., Galvão, S. L., de Paula, L. Z. M., Oliveira, M. E., Oliveira, I. D., da Silva, L. A., Freitas, V. H. M., Sales, C. R., et al. (2024) · Brazilian Journal of Clinical Medicine and Review · doi:10.52600/2965-0968.bjcmr.2023.2.3.22-28 · Cited by 3
Li, H., Zheng, C., Zheng, Y., Wen, K., & Zhang, Y. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110141 · Cited by 3
Modulation of ageing mice microglia functions during neuroinflammation using synthetic cannabinoids
Vijaya, A. K., Krisikaitytė, G., Kuras, S., Baltriukienė, D., & Burokas, A. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177705 · Cited by 3
Self-citationBagaev, A., Sur, D., Agranyoni, O., Pe'er, N., Savita, B. K., Rocha, B. G. S., Thanos, P. K., Navon‐Venezia, S., & Pinhasov, A. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03436-x · Cited by 3
Li, S., Yang, Y., Tian, G., Bai, J., Li, L., An, J., Zhang, Y., Li, X., Zhang, T., & Lv, H. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251389914 · Cited by 3
Yuan, R., Liu, F., & Yu, J. (2025) · Biomolecules and Biomedicine · doi:10.17305/bb.2025.13213 · Cited by 3
“Recently, the gut–brain axis (GBA) has emerged as a bidirectional network that integrates gut microbiota, immune function, and neural signaling [3].”
Rapaka, D., Saniotis, A., Monkgogi, T., & Bitra, V. R. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.118999 · Cited by 3
Medeiros, E. B., Lídio, A. V., Zabot, G. C., Fenilli, G. P., Silveira, G. D. B., Keller, G. S., Carrion, F. R. A., Felice, F. G. D., Kluwe‐Schiavon, B., Walss‐Bass, C., et al. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-10927-w · Cited by 4
Personalized medicine in old age psychiatry and Alzheimer’s disease
Siafarikas, N. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1297798 · Cited by 3
Amyloid, Crohn’s disease, and Alzheimer’s disease - are they linked?
Duda-Madej, A., Stecko, J., Szymańska, N., Miętkiewicz, A., & Szandruk-Bender, M. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1393809 · Cited by 3
Non-Immune Functions of Innate Immunity Acting on Physiological Processes: Insights from Drosophila
Li, X., Wang, X., Shang, Z., Yang, S., Tang, Y., & Xu, W. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031087 · Cited by 3
Psychoactive substances: novel molecular insights and therapeutic potential for Alzheimer's disease
Fu, C.-L., Li, X., Liu, X., Zheng, Y., Ma, X., Zhang, B., Chen, S. X., Hu, L., Su, S., Wang, X., et al. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00498-1 · Cited by 5
“Regulating the gut microbiota to promote the production of beneficial metabolites is a promising direction of AD treatment [50–52].”
Wan, S.-C., Wang, S., Zhang, X., Li, H., Sun, M., Chen, G., Wang, J., & Li, X. (2025) · Neurological Sciences · doi:10.1007/s10072-024-07976-w · Cited by 3
Surgical advances in the treatment of Alzheimer's disease: A comprehensive review
Xie, F., Ye, Y., Hao, J., Liu, H., Richard, S. A., & Sen, H. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251364397 · Cited by 6
Nutraceuticals to Mitigate the Secret Killers in Animals
Téllez‐Isaías, G., Eisenreich, W., & Shehata, A. A. (2022) · Veterinary Sciences · doi:10.3390/vetsci9080435 · Cited by 3
Impact of Intermittent Fasting on Alzheimer's Disease Risk: A Literature Review
Stencel, N. J., Szczot, J., Krala-Szkaradowska, M., Skrzypczak, K. O., & Stuczyński, S. K. (2024) · Quality in Sport · doi:10.12775/qs.2024.23.55272 · Cited by 2
Wang, Y., Zhu, X., He, Y., Lu, W., Wang, Z., & Liu, F. (2025) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-025-05294-1 · Cited by 2
“Microbial disorders can cause the progression of prostatitis through the microbiota-gut-brain axis, which can destroy the central nervous sys-tem, leading to conditions such as PD, AD, and depression [38–40].”
Constipation symptoms are associated with worse cognitive outcomes in older adults without dementia
Liu, X., Zhou, J. H., Xie, X., Zheng, W., Liu, D., Cheng, G., Hu, F., Wang, J., Cai, C., Liu, J., et al. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1578181 · Cited by 2
Zhang, L., Li, B., Ye, F., Li, L.-Z., Xiong, S., & Lei, S. S. (2026) · Phytotherapy Research · doi:10.1002/ptr.70197 · Cited by 2
“Enteric LPS is a key factor linking the “microbiota- gut-brain axis” (Megur et al. 2020; Suda and Matsuda 2022).”
Unmasking the hidden catalyst: How infections trigger Alzheimer's disease
Fülöp, T., Cohen, A. A., Frost, E. H., Lévesque, S., Khalil, A., Rodrigues, S., Desroches, M., Alami, M., Berrougui, H., Ramassamy, C., et al. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877251415571 · Cited by 2
Peng, L., Zhang, Z., Hu, Y., Chen, H., Tian, Y., & Ling, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1706811 · Cited by 2
Chen, B., Gg, C., Leng, X., Li, Q., Wu, W., Wu, W., Liu, Z., Zhong, Z., Zheng, X., Kang, W., et al. (2026) · Advanced Science · doi:10.1002/advs.202519949 · Cited by 2
Huang, S., Tu, C., Fei, Y., Wang, M., Deng, M., & Xia, J. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c17039 · Cited by 2
Unhealthy dietary patterns and Alzheimer’s disease: associations and underlying mechanistic pathways
Ramasinghe, C., & Xu, B. (2026) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2026.2691237 · Cited by 2
“The pro-inflammatory bacteria can release LPS into circulation, which in turn stimulates systemic and central immune responses (Megur et al. 2021; Das and Ganesh 2023).”
InfluentialWang, Q.-Q., Sun, Q.-Q., Guo, Y.-S., Yin, S., & Zhou, J. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00571-3 · Cited by 2
“Both disorders are associated with gut microbiota dysbiosis [344, 345] (Fig.”
Managing Intestinal Health in Farm Animals: A Critical View
Rostagno, M. H. (2022) · The microbiomes of humans, animals, plants, and the environment · doi:10.1007/978-3-030-90303-9_1 · Cited by 3
Pi, W.-X., Huan, X.-Y., Zhuang, Y., Zhang, J., Shi, X.-Q., & Zhou, G. (2022) · Journal of Liquid Chromatography & Related Technologies · doi:10.1080/10826076.2023.2182318 · Cited by 2
“[6] Currently, many breakthroughs have been made in BGA in regard to the pathogenesis of AD.”
BackgroundInfluentialWang, L., Yan, J., Liu, H., Zhao, X., Song, H., & Yang, J. (2023) · Neurodegenerative Diseases · doi:10.1159/000538023 · Cited by 2
Зв’язок між мікробіомом кишечника та розвитком нейродегенеративних захворювань (огляд)
Широбоков, В. П., & Димент, Г. С. (2024) · Visnik Nacional noi academii nauk Ukrai ni · doi:10.15407/visn2024.07.077 · Cited by 2
Infection, Neuroinflammation and Interventions for Healthy Brain and Longevity
Fülöp, T., Ramassamy, C., Lacombe, G., Frost, E. H., Cohen, A. A., Rodrigues, S., Desroches, M., Hirokawa, K., Laurent, B., & Witkowski, J. M. (2024) · Healthy ageing and longevity · doi:10.1007/978-3-031-68513-2_12 · Cited by 2
Role of microbiota-gut-brain axis in Alzheimer's disease and possible interventions
Pujari, R., Sharma, S., & Bhatt, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21680-0.00002-x · Cited by 3
Song, C., Zhou, L., Xiong, Y., Zhao, L., Guo, J., Zhang, L., Han, Y., Hu, Y., Xu, Y., Zhao, W., et al. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.118065 · Cited by 2
The Role of the Gut-Brain Axis in Alzheimer's Disease: A Narrative Review
Karout, L. (2022) · PDXScholar (Portland State University) · doi:10.15760/honors.1271 · Cited by 2
Mukhamedyarov, M. A., Akhmadieva, L. A., Nagiev, K. K., & Zefirov, A. L. (2023) · Annals of Clinical and Experimental Neurology · doi:10.54101/acen.2023.2.10 · Cited by 2
Le microbiote, un nouvel acteur dans le diagnostic de la maladie d’Alzheimer
Girodon, L., & Hauet, P. (2025) · médecine/sciences · doi:10.1051/medsci/2025019 · Cited by 2
Prajapati, C., Nand, S., Parmar, G. R., & Singh, S. K. (2025) · Interdisciplinary biotechnological advances · doi:10.1007/978-981-95-2104-3_14 · Cited by 1
Fernández, S. J. F., Aparicio, J. G. P., López, L. F. J., Casillas, M. C., Quijano, M., Valle, I. M., Ponce, A. K. G., & Tarazona, M. A. C. (2025) · IECCMEXICO · doi:10.64784/021 · Cited by 1
Evidence of an anti-inflammatory diet as a key protector for subjective memory complaints in women
de Coca, T. L., Sala‐Climent, M., Bosch, L., Heras-Santos, N. D. L., Muñoz–Almaraz, F. J., & Moreno, L. (2025) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-025-05195-0 · Cited by 1
“Polyphenols also affect microbiota-related metabolism, with anthocyanins, recently shown to enhance proinflammatory cytokines, that potentially prevent neuroin-flammation in AD [10].”
Yang, Y., Yang, F., Yao, M., Li, L., & Li, H. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261427028 · Cited by 1
Zhao, R., Wang, Y., Zhu, Z., Qi, Y., Yang, X., Luo, Y., Zhang, X., Li, L., Hong, H., Liu, Y., et al. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108226 · Cited by 1
Megur, A., & Kumar, B. (2026) · Food Reviews International · doi:10.1080/87559129.2026.2649298 · Cited by 1
“[129,130] Certain gut bacteria have been shown to modulate microglial activation and cytokine production, highlighting the potential of microbiota-targeted interventions in neuroin-flammatory disorders.”
Self-citationAtzeni, A., Mingaila, J., Alzbutas, G., Lukoševičius, R., Drūteika, J., Łuczyńska, K., Ramonaitė, R., Pietras, T., Sipowicz, K., Kiudelytė, D., et al. (2026) · Aging Cell · doi:10.1111/acel.70488 · Cited by 1
“Alterations in microbial diversity and composition have been documented in both AD and T2DM (Cryan et al. 2020; Megur et al. 2020, 2022; Zhuang et al. 2018), with overlapping enrichment of pro-inflammatory genera and depletion of beneficial taxa (Zhang et al. 2022).”
Self-citationThe gut–brain axis: mechanisms linking intestinal dysbiosis with stroke
Santos, J. T. G., Tornero, D., & Karam, M. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1854765 · Cited by 1
“SCFAs, including butyrate, have demonstrated protective roles in neurodegenerative disorders and cerebral ischemia by attenuating proinflammatory macrophage and microglial responses (Hasavci and Blank, 2022; Moţăţăianu et al., 2023; Megur et al., 2021).”
Amruthavarshini, S. N., Kumari, N., & Anand, S. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06015-3 · Cited by 1
Medeiros, E. B., Monteiro, I. D. O., Kluwe‐Schiavon, B., Possamai, O. L., Fenilli, G. P., Keller, G. S., Lídio, A. V., Casagrande, D. D., Souza, C. S. M., Silveira, G. D. B., et al. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-11104-9 · Cited by 1
Biological activities of tea seed (Camellia oleifera Abel.) oil
Liew, F. F., Chan, K. W., & Ooi, D. J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824135-6.00022-2 · Cited by 1
Stavrovskaya, A. V., Даниленко, В. Н., Воронков, Д. Н., Гущина, А. С., Марсова, М. В., Olshansky, A. S., Yamshikova, N. G., & Illarioshkin, S. N. (2021) · Human Physiology · doi:10.1134/s0362119721080120 · Cited by 1
“Moreover, higher expression of TLR-2, TNF-α, and IL-6 was observed in the rat brain, indicating that amyloids produced by bacteria trigger α-Syn aggregation and, consequently, a response of the innate immunity system [49, 50].”
BackgroundDiet and Microbiome in Health and Aging
González, S., Salazar, N., & Arboleya, S. (2022) · MDPI eBooks · doi:10.3390/books978-3-0365-5364-1 · Cited by 1
Gulrandhe, P., Acharya, S., Shukla, S., & Patel, M. (2023) · Cureus · doi:10.7759/cureus.44819 · Cited by 4
“The specific composition of the microbiota is influenced by the host's genetics and nutrition, emphasizing the need for more research on the microbiota-gut-brain involvement in AD to develop novel therapeutic targets and strategies [16].”
BackgroundYeske, B., Hou, J., Chu, D. Y., Adluru, N., Nair, V. A., Beniwal-Patel, P. M., Saha, S., & Prabhakaran, V. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1210939 · Cited by 1
田, 格. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.142347 · Cited by 1
Oleksak, I., Leśniewski, M., Welian-Polus, I., Maliszewska, K., & Ziółkowska, J. (2024) · Journal of Education Health and Sport · doi:10.12775/jehs.2024.57.005 · Cited by 1
Modeling Taupathies in Zebrafish (Danio rerio)
Kotova, M. M., Kolesnikova, T. O., & Kalueff, A. V. (2023) · Российский физиологический журнал им И М Сеченова · doi:10.31857/s0869813923110067 · Cited by 1
Avaliação da microbiota intestinal e uso de probióticos na doença de Alzheimer
da Rosa, J. C. P., Lopes, I. G. C., Rainieri, A. L., Cardoso, R. D. R., & Lage, P. S. (2024) · Debates em Psiquiatria · doi:10.25118/2763-9037.2024.v14.1346 · Cited by 1
Apolipoprotein E ε4-Specific Relationship Between Serum Olfactomedin 4 and Alzheimer’s Disease
Wei, C., Zhang, G., Fu, X., Zhao, M. L., Zhai, W., Shen, Y., & Sun, L. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04812-w · Cited by 1
“This cascade leads to increased Aβ plaque deposition [32] and contributes to neuronal degeneration in AD [33].”
Causal associations and shared genetic etiology between neurodegenerative diseases and constipation
Sun, W., Zhu, A., Chang, H., Xia, J., Gao, J., Zhang, Z., Chi, F., Zhu, Y., & Bao, X. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251362469 · Cited by 1
Forgham, H., Albornoz, E. A., Pietrogrande, G., Munir, M. U., Zhu, J., Anjum, M. A., Chung, K. H. K., Tahir, M. S., Ali, S. A., Käkinen, A., et al. (2026) · npj Dementia · doi:10.1038/s44400-026-00122-7 · Cited by 1
Khatoon, R., Ghani, M., Shahzad, S., Siddiqa, M., Azmat, M., Zafar, I., & Shafiq, S. (2025) · Indus journal of bioscience research. · doi:10.70749/ijbr.v3i2.733 · Cited by 1
Zhou, G., Zhang, J., Huan, X.-Y., Zhuang, Y., Xu, S.-Y., Liu, J.-S., Tan, Y., Tao, H., Chen, J., Pu, Z., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3937061 · Cited by 1
Planta Medica International Open
Radad, R. M. A. U. C. K. B. K. K. (2022) · Planta Medica International Open · doi:10.1055/s-00032099 · Cited by 1
Diet and Microbiome in Health and Aging
Arboleya, S., González, S., & Salazar, N. (2022) · Nutrients · doi:10.3390/nu14163250 · Cited by 1
Matías-Pérez, D., & García-Montalvo, I. A. (2021) · Archives of Neuroscience · doi:10.5812/ans.119948
Recent advances in blood and gut microbiota biomarkers for Alzheimer’s disease
Wu, S., Li, H., Tong, L., & Zhou, L. I. U. (2021) · Scientia Sinica Vitae · doi:10.1360/ssv-2021-0100
I Encontro Acadêmico de Neurologia, Neurocirurgia e Neurociências
Gerais, U. F. D. M. (2021) · REVISTA CIÊNCIAS EM SAÚDE · doi:10.21876/rcshci.v11i3.1198
Piana, G. S., Batista, C. D. C. L., Contão, H. D. O., Lopes, K. A., Silva, L. T. D., Cardoso, T. C., de Assunção, G. N., ZAMPROGNO, S. B., Cavalcante, R. L. D. C., Borges, S. R. A., et al. (2022) · International Journal of Health Science · doi:10.22533/at.ed.159312301013
Study on the Effect of Blood Pressure on the Physiological Mechanism of Alzheimer’s Disease
许, 斯. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.12111451
Focused Ultrasound Blood – Brain Barrier Opening Alters the Murine Microbiome
Kline-Schoder, A. R., Bendig, J., Gorman, S. L., Jimenez, D. A., & Konofagou, E. E. (2023) · IEEE International Ultrasonics Symposium · doi:10.1109/ius51837.2023.10306632
“Moreover, other studies have found that the microbiota of aged, Alzheimer’s disease affected individuals have a lower level of bacteria, resulting in decreased butyrate levels and increased inflammation of the brain and as well as the progression of cognitive loss [3].”
BackgroundInfluentialЮрко, К. В., Соломенник, Г. О., & Кучерявченко, В. В. (2023) · Інфекційні хвороби · doi:10.11603/1681-2727.2023.4.14248
Modeling Tauopathies in Zebrafish (Danio rerio)
Kotova, M. M., Kolesnikova, T. O., & Kalueff, A. V. (2023) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093023060133
Metadata
- Authors
- Megur, A., Baltriukienė, D., Bukelskienė, V., & Burokas, A.
- Affiliations
- Vilnius University (LT)
- Corresponding author
- Burokas, Aurelijus
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2020-12-24
- Volume
- 13
- Issue
- 1
- Pages
- 37
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC7824474
- OpenAlex
- W3115136688
- Cited by
- 323
- References
- 253
- Citations by year
- 2026: 44 · 2025: 75 · 2024: 75 · 2023: 54 · 2022: 57 · 2021: 18
- FWCI
- 3.09
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- The European Regional Development Fund under grant agreement with the Research Council of Lithuania (LMTLT) (01.2.2-LMT-K-718-02-0014)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, microbiota-gut-brain axis, gut dysbiosis, neuroinflammation, blood-brain barrier, intestinal permeability, lipopolysaccharide, bacterial amyloids, probiotics, antibiotics, dementia
- MeSH terms
- Gastrointestinal Microbiome, Alzheimer Disease, Animals, Anti-Bacterial Agents, Brain, Encephalitis, Humans, Intestines, Probiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.